Losartan Potassium And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 72189-325

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Losartan Potassium And Hydrochlorothiazide (NDC 72189-325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72189 325 30

72189 325 30
Loartaran Potassium/HCTZ 50/12.5 mg film-coated tablets package label showing 30 tablets. The label indicates the product contains Losartan Potassium 50 mg and Hydrochlorothiazide 12.5 mg, is generic for Hyzaar, and is packaged and distributed by Direct Rx. Additional product and lot details are printed on side labels.*
FDA Label Image

Fhtyfgh (72189 325 90)

Fhtyfgh (72189 325 90)
Packaging label for Losartan Potassium and Hydrochlorothiazide tablets, film coated, oral dosage form, with strengths of 50 mg Losartan Potassium and 12.5 mg Hydrochlorothiazide. The label indicates a bottle containing 90 tablets, marketed under the proprietary name Hyzaar by Direct Rx. It includes NDC 72189-325 and other regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.